Polychromatic angiography for the assessment of VEGF-induced BRB dysfunction in the rabbit retina

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5550-5558

  Tari, Samir R ^a   Youssif, Maher ^a   Samson, C Michael ^b   Harris, Robert L ^c   Lin, Cheng Mao ^d   Kompella, Uday B ^e   Antonetti, David A ^d   Barile, Gaetano R ^f  

^a PCAsso Diagnostics LLC   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f EAR AND THROAT HOSPITAL   (United States)

Author keywords

Blood retinal barrier; Polychromatic angiography; Retina; Retinal imaging

Indexed keywords

BEVACIZUMAB; CONTRAST MEDIUM; CY5 DEXTRAN 40; FLUORESCEIN SODIUM; INDOCYANINE GREEN; PCM 102; PCM 107; TETRAMETHYLRHODAMINE DEXTRAN 10; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD RETINAL BARRIER DYSFUNCTION; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; MALE; NONHUMAN; POLYCHROMATIC ANGIOGRAPHY; PRIORITY JOURNAL; RABBIT; RETINA BLOOD VESSEL; RETINA DISEASE; SCORING SYSTEM;

BLOOD RETINAL BARRIER; POLYCHROMATIC ANGIOGRAPHY; RETINA; RETINAL IMAGING;

ANIMALS; BLOOD-RETINAL BARRIER; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; INTRAVITREAL INJECTIONS; MALE; RABBITS; RETINA; RETINAL DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84882801963     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12144     Document Type: Article

References (18)

1. Smith RT, Lee CM, Charles HC, Farber M, Cunha-Vaz JG. Quantification of diabetic macular edema. Arch Ophthalmol. 1987;105:218-222.
2. Lobo CL, Bernardes RC, Santos FJ, Cunha-Vaz JG. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous. Arch Ophthalmol. 1999; 117:631-637.
3. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
4. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816.
5. Phillips RP, Ross PG, Tyska M, Sharp PF, Forrester JV. Detection and quantification of hyperfluorescent leakage by computer analysis of fundus fluorescein angiograms. Graefes Arch Clin Exp Ophthalmol. 1991;229:329-335.
6. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998;105:360-370.
7. Salminen L, Chioralia G, Schreiber S. Distribution of intravenously injected dextrans in the posterior part of the rat eye. Bibl Anat. 1977;16:69-72.
8. Chioralia G, Salminen L, Baurmann H, Kremer F. Fluoresceinlabelled dextrans as tracer substance for experimental angiograms. Acta Ophthalmol (Copenh). 1976;54:665-667.
9. Rabkin MD, Bellhorn MB, Bellhorn RW. Selected molecular weight dextrans for in vivo permeability studies of rat retinal vascular disease. Exp Eye Res. 1977;24:607-612.
10. Bellhorn MB, Bellhorn RW, Poll DS. Permeability of fluorescein-labelled dextrans in fundus fluorescein angiography of rats and birds. Exp Eye Res. 1977;24:595-605.
11. Salminen L, Chioralia G, Schreiber S. Effect of acute ocular hypotony on the blood-ocular barrier. Trans Ophthalmol Soc U K. 1977;97:621-622.
12. McNaught EI, Foulds WS, Johnson NF. The permeability of the posterior blood ocular barrier after xenon photocoagulation: a study using fluorescein labeled dextrans. Br J Ophthalmol. 1981;65:473-477.
13. Lightman SL, Caspers-Velu LE, Hirose S, et al. Angiography with fluorescein-labeled dextrans in a primate model of uveitis. Arch Ophthalmol. 1987;105:844-848.
14. Atkinson EG, Jones S, Ellis BA, et al. Molecular size of retinal vascular leakage determined in patients with posterior uveitis. Eye. 1991;5:440-446.
15. Arana LA, Pinto AT, Chader GJ, et al. Fluorescein angiography, optical coherence tomography, and histopathologic findings in a VEGF(165) animal model of retinal angiogenesis. Graefes Arch Clin Exp Ophthalmol. 2012;250:1421-1428.
16. Phillips BE, Cancel L, Tarbell JM, Antonetti DA. Occludin independently regulates permeability under hydrostatic pressure and cell division in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2008;49:2568-2576.
17. Saati S, Agrawal RN, Louie S, Chader GJ, Humayun MS. Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascularmodel in rabbits. Graefes Arch Clin Exp Ophthalmol. 2010;248:457-466.
18. Ameri H, Chader GJ, Kim JG, Sadda SR, Rao NA, Humayun MS. The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci. 2007;48:5708-5715.